ADIPOQ single nucleotide polymorphism: Association with adiponectin and lipoproteins levels restricted to men

Meta Gene

Volumn 5, Issue , 2015, Pages 98-104

  Tureck, Luciane Viater ^a,b   Leite, Neiva ^a,c   Souza, Ricardo Lehtonen Rodrigues ^a,b   da Silva Timossi, Luciana ^a,c   Osiecki, Ana Claudia Vecchi ^a,c   Osiecki, Raul ^a,c   Alle, Lupe Furtado ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

^c Coração deMaria ^*  (Brazil)

Author keywords

276G>T SNP; Adiponectin; ADIPOQ gene; Gender effect; Lipid metabolism

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOTE; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NORMAL HUMAN; OBESITY; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84931281815     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2015.06.003     Document Type: Article

References (57)

1. Al-Daghri N.M., Al-Attas O.S., Alokail M.S., Alkharfy K.M., Hussain T., Yakout S., Vinodson B., Sabico S. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 2012, 493:142-147.
2. Alsaleh A., Crepostnaia D., Maniou Z., Lewis F.J., Hall W.L., Sanders T.A., O'Dell S.D., MARINA study team Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals. J. Nutr. 2013, 143:1021-1027.
3. Arikoglu H., Ozdemir H., Kaya D.E., Ipekci S.H., Arslan A., Kayis S.A., Gonen M.S. The adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene 2014, 534:10-16.
4. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
5. Caselli C. Role of adiponectin system in insulin resistance. Mol. Genet. Metab. 2014, 113:155-160.
6. Cesari M., Narkiewicz K., De Toni R., Aldighieri E., Williams C.J., Rossi G.P. Heritability of plasma adiponectin levels and body mass index in twins. J. Clin. Endocrinol. Metab. 2007, 92:3082-3088.
7. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 2003, 278:45021-45026.
8. Cheung C.Y.Y., Hui E.Y., Cheung B.M., Woo Y.C., Xu A., Fong C.H., Ong K.L., Yeung C.Y., Janus E.D., Tse H.F., Sham P.C., Lam K.S. Adiponectin gene variants and the risk of coronary heart disease: a 16-year longitudinal study. Eur. J. Endocrinol. 2014, 171:107-115.
9. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
10. Combs T.B., Pajvani U.B., Berg A.H., Lin Y., Jelicks L.A., Laplante M., Nawrocki A.R., Rajala M.V., Parlow A.F., Cheeseboro L., Ding Y.Y., Russell R.G., Lindemann D., Hartley A., Baker G.R.C., Obici S., Deshaies Y., Ludgate M., Rossetti L., Scherer P.E. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004, 145:367-383.
11. De Vries R., Wolffenbuttel B.H., Sluiter W.J., VanTol A., Dullaart R.P. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clin. Lab. 2005, 51:403-409.
12. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2005-2010.
13. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
14. Gable D.R., Hurel S.J., Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006, 188:231-244.
15. Gao M., Ding D., Huang J., Qu Y., Wang Y., Huang Q. Association of genetic variants in the adiponectin gene with metabolic syndrome: a case-control study and a systematic meta-analysis in the Chinese population. PLoS ONE 2013, 8. e58412.
16. Haluzík M., Parízková J., Haluzík M.M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol. Res. 2004, 53:123-129.
17. Hand L.E., Usan P., Cooper G.J.S., Xu L.Y., Ammori B., Cunningham P.S., Aghamohammadzadeh R., Soran H., Greenstein A., Loudon A.S.I., Bechtold D.A., Ray D.W. Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit. Diabetes 2015, 64:128-136.
18. Heid I.M., Wagner S.A., Gohlke H., Iglseder B., Mueller J.C., Cip P., Ladurner G., Reiter R., Stadlmayr A., Mackevics V., Illig T., Kronenberg F., Paulweber B. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
19. Heid I.M., Wagner S.A., Gohlke H., Iglseder B., Mueller J.C., Cip P., Ladurner G., Reiter R., Stadlmayr A., Mackevics V., Illig T., Kronenberg F. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes 2006, 55:375-384.
20. Heid I.M., Henneman P., Hicks A., Coassin S., Winkler T., Aulchenko Y.S., Fuchsberger S., Song K., Hivert M.F., Waterworth D.M. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
21. Henneman P., Janssens A.C., Zillikens M.C., Frolich M., Frants R.R., Oostra B.A., Van Duijn C.M., Van Dijk K.W. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome. J. Intern. Med. 2010, 267:402-409.
22. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama Y., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto M., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
23. Kawai T., Ohishi M., Takeya Y., Onishi M., Ito N., Yamamoto K., Oguro R., Kamide R., Rakugi H. Adiponectin single nucleotide polymorphism is a genetic risk factor for stroke through high pulse wave pressure: a cohort study. J. Atheroscler. Thromb. 2013, 22:152-160.
24. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89:2548-2556.
25. Kersten S. Physiological regulation of lipoprotein lipase. Biochim. Biophys. Acta 2014, 1841:919-933.
26. Khabour O.F., Wehaibi S.H., Al-Azzam S.I., Alzoubi K.H., El-Akawi Z.J. Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect. Clin. Exp. Hypertens. 2013, 35:361-366.
27. Kovanen P.T., Brown M.S., Goldstein J.L. Increased binding of low density lipoproteins to liver membranes treated with 17α-ethinyl estradiol. J. Biol. Chem. 1979, 254:11367-11373.
28. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., Noda T. Disruption adiponectin causes insulin resistance neointimal formation. J. Biol. Chem. 2002, 277:25863-25866.
29. Kuusi T., Ehnholm C., Viikari J., Harkonen R., Vartiainen E., Puska P., Taskinen M.R. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J. Lipid Res. 1989, 30:1117-1126.
30. Lahiri D.K., NurnbergerJr J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19:5444.
31. Lara-Castro C., Fu Y., Chung B.H., Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr. Opin. Lipidol. 2007, 18:263-270.
32. Lu J.F., Zhou Y., Huang G.H., Jiang H.X., Hu B.L., Qin S.Y. Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. Hum. Immunol. 2014, 75:1062-1068.
33. Melistas L., Mantzoros C.S., Kontogianni M., Antonopoulou S., Ordovas J.M., Yiannakouris N. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur. J. Endocrinol. 2009, 161:845-852.
34. Miljkovic-Gacica I., Wangb X., Kammererb C.M., Bunkera C.H., Wheelerc V.W., Patrickc A.L., Kullera L.H., Evansa R.W., Zmuda J.M. Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage. Metabolism 2007, 56:234-238.
35. Nawrocki A.R., Scherer P.E. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr. Opin. Pharmacol. 2004, 4:281-289.
36. Nikkila E.A., Kuusi T., Taskinen M.R., Tikkanen M. Regulation of lipoprotein metabolism by endothelial lipolytic enzymes. Treatment of Hyperlipoproteinemia 1984, 77-84. Raven Press, New York. L.A. Carlson, A.G. Olsson (Eds.).
37. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuda M., Kondo H., Furuyama N., Kihara S., Nakamura T., Tochino Y., Funahashi T., Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
38. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama K., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
39. Ouyang S., Cao D., Liu Z., Ma F., Wu J. Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose. Endocrine 2014, 47:749-757.
40. Pollin T.I., Tanner K., O'Connell J.R., Ott S.H., Damcott C.M., Shuldiner A.R., McLenithan J.C., Mitchell B.D. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the ADIPOQ gene. Diabetes 2005, 54:268-274.
41. Pyrzak B., Ruminska M., Czerwonogrodzka-Senczyna A., Majcher A., Wisniewska A., Brzewski M., Demkow U. Association of adiponectin gene G276T polymorphism with atherogenic indicators in obese children. Adv. Exp. Med. Biol. 2013, 756:247-254.
42. Qi L., Li T., Rimm E., Zhang C., Rifai N., Hunter D., Doria A., Frank H.B. The 276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic Men. Diabetes 2005, 54:1607-1610.
43. Qiao L., Zou C., Van der Westhuyzen D.R., Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 2008, 57:1824-1833.
44. Ramya K., Ayyappa K.A., Ghosh S., Mohan V., Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013, 532:253-262.
45. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004, 68:975-981.
46. Saiki A., Oyama T., Endo K., Ebisuno M., Ohira M., Koide N., Murano T., Miyashita Y., Shirai K. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res. Clin. Pract. 2007, 76:93-101.
47. Saunders T.J., Palombella A., McGuire K.A., Janiszewski P.M., Després J.P., Ross R. Acute exercise increases adiponectin levels in abdominally obese men. J. Nutr. Metab. 2012, 2012:1-6.
48. Schneider J.G., Von Eynatten M., Schiekofer S., Nawroth P.P., Dugi K.A. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005, 28:2181-2186.
49. Sorva R., Kuusi T., Dunkel L., Taskinen M.R. Effects of endogenous sex steroids on serum lipoproteins and post heparin plasma lipolytic enzymes. J. Clin. Endocrinol. Metab. 1988, 66:408-413.
50. Taskinen M.R., Kuusi T. High density lipoproteins in postprandial lipemia: relation to sex and lipoprotein lipase activity. Atherosclerosis 1986, 9:121-130.
51. The Lipid Research Clinics Program Epidemiology Committee Plasma lipid distribution in selected North American populations: the lipid research clinics program prevalence study. Circulation 1979, 60:427-439. [no authors listed].
52. Tudor-Locke C., Craig C.L., Brown W.J., Clemes A.S., De Cocker K., Giles-Corti B., Hatano Y., Inoue S., Matsudo S.M., Mutrie N., Oppert J.M., Rowe D.A., Schmidt M.D., Schofield G.M., Spence J.C., Teixeira P.J., Tully M.A., Blair N.S. How many steps/day are enough for adults?. Int. J. Behav. Nutr. Phys. Act. 2011, 8:1-17.
53. Von Eynatten M., Schneider J.G., Humpert P.M., Rudofsky G., Schmidt N., Barosch P., Hamann A., Morcos M., Kreuzer J., Bierhaus A., Nawroth P.P., Dugi K.A. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004, 27:2925-2929.
54. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
55. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes. Metab. 2006, 8:264-280.
56. Wyatt H.R., Peters J.C., Reed G.W., Barry M., Hill J.O. A Colorado statewide survey of walking and its relation to excessive weight. Med. Sci. Sports Exerc. 2005, 37:724-730.
57. Zhao T., Zhao Z. Genetic effects of adiponectin on blood lipids and blood pressure. Clin. Endocrinol. 2011, 74:214-222.